Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Pascal Biosciences and Y-Biologics Announce Research Collaboration for Development of a Bispecific Antibody for Leukemia
Wednesday, October 30, 2019Pascal Biosciences Inc and YBiologics today announced a research collaboration agreement for the discovery and development of novel bispecific antibodies for the treatment of leukemia Under the terms of the agreement YBiologics will contribute its no...
Gotham Therapeutics Establishes Advanced Oncology Profiling Cascade with ProQinase to Progress its Portfolio of Epitranscriptomic Drug Candidates
Wednesday, October 30, 2019Gotham Therapeutics a biotechnology company developing a novel drug class targeting RNAmodifying proteins and ProQinase an early stage drugdiscovery company recently acquired by MalvernPAbased Reaction Biology Corp today announced that they have esta...
Gilead and Glympse Bio Announce Strategic Collaboration for Use of Biomarker Technology in NASH Clinical Development
Tuesday, October 29, 2019Gilead Sciences Inc and Glympse Bio Inc today announced that the companies have entered into a strategic collaboration in nonalcoholic steatohepatitis NASH clinical development Glympse Bios proprietary synthetic biomarkers bioengineered to identify...
Ziopharm Oncology and MD Anderson Cancer Center Announce New R&D Agreement to Expand TCR-T Program
Tuesday, October 29, 2019Ziopharm Oncology Inc and The University of Texas MD Anderson Cancer Center today announced a new research and development agreement relating to Ziopharms Sleeping Beauty immunotherapy program to use nonviral gene transfer to stably express and clini...
HistoIndex Announces Global Partnerships To Expand AI-Based Digital Pathology Platform
Monday, October 28, 2019HistoIndex announces the expansion of its AIbased digital pathology platform towards largescale NASH preclinical programs for pharmaceutical and biotech companies to achieve quantifiable and reproducible data on therapeutic responses in NASH animal m...
AVROBIO Receives Orphan-Drug Designation from the U.S. FDA for AVR‑RD‑02 for the Treatment of Gaucher Disease
Friday, October 25, 2019AVROBIO Inc today announced that the US Food and Drug Administration FDA has granted orphandrug designation for the Companys investigational gene therapy AVRRD for the treatment of Gaucher disease AVRRD consists of the patients own hematopoietic stem...
AZTherapies Strengthens Neuroinflammation-Targeted Pipeline Through Acquisition of Smith Therapeutics
Friday, October 25, 2019AZTherapies Inc a biopharmaceutical company developing therapeutics to extend brain health today announced the acquisition of Smith Therapeutics a private biopharmaceutical company with a shared goal of targeting neuroinflammation to treat neurodegen...
Foamix Enters Into Manufacturing and Supply Agreement For AMZEEQ™ and FMX103
Thursday, October 24, 2019Foamix Pharmaceuticals Ltd a specialty pharmaceutical company today announced that it has entered into a long term contract manufacturing and supply agreement with ASM AerosolService ASM for the Companys recently approved AMZEEQ minocycline topical f...
Pliant Therapeutics Announces Strategic Collaboration to Develop Novel Therapies for NASH and Fibrotic Diseases
Thursday, October 24, 2019Pliant Therapeutics Inc a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis today announced it has entered into a strategic collaboration and license agreement with Novartis c...
Zealand Pharma expands its peptide platform with acquisition of Encycle Therapeutics
Wednesday, October 23, 2019Zealand Pharma AS a Copenhagenbased biotechnology company focused on the discovery and development of innovative peptidebased medicines announces the acquisition of Encycle Therapeutics Inc a private Torontobased biotech company exploiting a unique p...
